Lanean...
Selecting and engineering monoclonal antibodies with drug-like specificity
Despite the recent explosion in the use of monoclonal antibodies (mAbs) as drugs, it remains a significant challenge to generate antibodies with a combination of physicochemical properties that are optimal for therapeutic applications. We argue that one of the most important and underappreciated dru...
Gorde:
| Argitaratua izan da: | Curr Opin Biotechnol |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6829062/ https://ncbi.nlm.nih.gov/pubmed/30822699 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.copbio.2019.01.008 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|